Abstract
Initial clinical trials of an antipregnancy vaccine consisting of the β-subunit of human chorionic gonadotropin linked to tetanus toxoid (β-hCG-TT) and adsorbed on Al (OH)3 resulted in low and short-lived antibody titers in some of the women studied (1,2). It was therefore judged necessary to find ways to enhance the antibody response. Approaches explored included the use of other adjuvants to supplement the aluminum hydroxide and the use of modified vehicles. The effectiveness of these expedients was evaluated by vaccinating rabbits and measuring the concentration in serum of antibodies capable of binding labeled hCG. In selected instances, the ability of the antiserum to inhibit stimulation by hCG of uterine growth in immature rats was also measured. Some of the findings have been reported in earlier publications (3,4). They are summarized and extended in the present review.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Nash, H., Talwar, G. P., Segal, S., Luukkainen, T., Johansson, E.D.B., Vasquez, J., Coutinho, E., and Sundaram, K. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: β-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil. Steril. 34: 328 (1980).
Shahani, S.M., Kulkarni, P.P., Patel, K.L., Salahuddin, M., Das, C., and Talwar, G.P. Clinical and immunological responses with Pr-β-hCG-TT vaccine. Contraception 25: 421 (1982).
Nash, H.A., Chang, C.C., and Tsong, Y.Y. Formulation of a potential antipregnancy vaccine based on the β-subunit of human chorionic gonadotropin (β-hCG). Use of compounds of the muramyl dipeptide (MDP) family as adjuvants. J. Reprod. Immunol. 7:151 (1985).
Chang, C.C., Tsong, Y.Y., and Nash, H.A. Formulation of a potential antipregnancy vaccine based on the β-subunit of human chorionic gonadotropin (β-hCG). III. Evaluation of various vehicles and adjuvants. J. Reprod. Immunol. 7:163 (1985).
Tsong, Y.Y., Chang, C.C., and Nash, H.A. Formulation of a potential antipregnancy vaccine based on the β-subunit of human chorionic gonadotropin (β-hCG). I. Alternative macrcmolecular carriers. J. Reprod. Immunol. 7:139 (1985).
Siddiqui, W.A., Taylor, D.W., Kan, S.-C., Kramer, K., Richmond-Crum, S.M., Kotani, S., Shiba, T., and Kusunoto, S. Vaccination of experimental monkeys against Plasmodium falciparum; a possible safe adjuvant. Science 201:1237 (1978).
Audibert, F., Parant, M., Damais, C., Lefrancier, P., Derrien, M., Choay, J., and Chedid, L. Dissociation of immunostimulant activities of muranyl dipeptide (MDP) by linking amino acids or peptides to the glutaminyl residue. Biochem. Biophys. Res. Commun. 96:915 (1980).
Jolivet, M., Sache, E., and Audibert, F. Biological studies of lipophilic MDP derivatives incorporated in liposomes. Immunol. Commun. 10:511 (1981).
Hunter, R., Strickland, F., and Kezdy, F. The adjuvant activity of nonionic block polymer surfactants. I. The role of lydrophilelipophile balance. J. Immunol. 127:1244 (1981).
Snippe, H., DeReuver, M. J., Strickland, F., Willers, J.M.N., and Hunter, R.L. Adjuvant effect of nonionic block surfactants in humoral and cellular immunity. Int. Arch. Allergy Appl. Immunol. 65:390 (1981).
Elin, R.J., Wolff, S.M., McAdam, K.P.W.J, Chedid, L., Audibert, F., Barnard, C., and Aberling, F. Properties of reference Eschrechia coli endotoxin and its phthalylated derivative in humans. J. Infect. Dis. 144: 329 (1981).
Niblack, J.F., Otterness, I.G., Hemsworth, G.R., Wolff, J.S. III, Hoffman, W.W., and Kraska, A.R. CP-20,961: A structurally novel synthetic adjuvant. J. Reticuloendothel. Soc. 26: 655 (1979).
Anderson, A.O. and Reynolds, J.A. Adjuvant effects of the lipid amine CP 20,961. J. Reticuloendothel. Soc. 26: 667 (1979).
Hilgers, A.Th.H, Snippe, H., Jansze, M., and Willers, J.M.N. Immuno-modulating properties of two synthetic adjuvants: Dependence on type of antigen, dose and time of administration. Cellular Immunol. 86: 393 (1984).
Friedman, H. Immuncmodulation by small molecular weight bacterial products. Adv. Exptl. Med. Biol. 166: 199 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Nash, H.A., Chang, C.C., Tsong, Y.Y. (1986). Enhancement of Antibody Response to an Antigonadotropin Vaccine by use of Adjuvants. In: Talwar, G.P. (eds) Immunological Approaches to Contraception and Promotion of Fertility. Reproductive Biology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5140-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5140-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5142-9
Online ISBN: 978-1-4684-5140-5
eBook Packages: Springer Book Archive